NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10
TD Cowen analyst Brendan Smith maintains $Ginkgo Bioworks(DNA.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 42.1% and a
Express News | Ginkgo Bioworks Holdings Inc : TD Cowen Raises Target Price to $10 From $3
TD Cowen Initiates Ginkgo Bioworks(DNA.US) With Buy Rating, Announces Target Price $10
TD Cowen analyst Brendan Smith initiates coverage on $Ginkgo Bioworks(DNA.US)$ with a buy rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 42.1%
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks Executive Sells Over $1,900 in Stock
Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy?
Ginkgo Bioworks Awarded $118M U.S. Government HHS Contract
Ginkgo Regains Compliance With NYSE Minimum Bid Price Requirement
NYSE to Commence Delisting Proceedings With Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7
BTIG analyst Mark Massaro maintains $Ginkgo Bioworks(DNA.US)$ with a sell rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 31.4% and a total
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Adjusts Price Target To $7 (1-40 Reverse Stock Split)